AdvaMed is saddened to share that a beloved member of the AdvaMed family, Wendy Siminski, Senior Vice President of Conferences and Events, has passed away after a brave battle with breast cancer.

March 7, 2022 — AdvaMed is saddened to share that a beloved member of the AdvaMed family, Wendy Siminski, Senior Vice President of Conferences and Events, has passed away after a brave battle with breast cancer. President and CEO Scott Whitaker released the following tribute:

“Wendy embodied the very best of AdvaMed, and her optimistic, ambitious spirit inspired everyone around her to rise to meet her unwavering standard of excellence. You’d never catch Wendy without a big smile and a list of ideas to leave a project better than she found it. The MedTech Conference is successful today because of Wendy’s hard work and determination. 

“Wendy was confident, collaborative, and courageous until the very end. She was a bright light on our team, and that light will continue to guide us and give us warmth in the months and years to come. At AdvaMed, the patients we serve motivate us; Wendy is no exception, and, in fact, she’s the perfect example. Her fight with cancer drives us all to fight harder for medtech innovation, so perhaps future generations – even Wendy’s own daughters – can conquer this terrible disease once and for all.

“We will miss Wendy dearly, and we’re sending comfort, peace, and strength to her family during this difficult time.”

As Senior Vice President, Wendy served as a lead planner for The MedTech Conference, AdvaMed’s annual flagship conference for the medical technology industry, and all other AdvaMed events and conferences. Her efforts grew the Conference’s programming footprint – at the 2020 conference alone, participants could access more than 150 sessions featuring more than 500 speakers – as well as the conference’s standards for inclusion and diversity – at the 2020 conference, women and minorities were represented in 95% of session panels. Prior to her time at AdvaMed, Wendy led teams at BIO, the AUVSI Foundation, O’Keefe Communications, National Trade Productions, and the Cellular Telecommunications and Internet Association.

Wendy was also a fierce patient advocate for the medtech industry; you can read her profile in AdvaMed’s Story of MedTech series here.

She is survived by her two daughters, Kira and Ashley.

In lieu of flowers, Wendy’s family requests that donations be made in Wendy’s honor to METAvivor. One-hundred percent of all donations made to METAvivor go directly to fund grant awards for metastatic breast cancer research.

For more information: www.advamed.org


Related Content

News | ASTRO

May 17, 2024 — Registration opens today for the American Society for Radiation Oncology's (ASTRO) 66th Annual Meeting ...

Time May 17, 2024
arrow
News | Enterprise Imaging

May 16, 2024 — AGFA HealthCare announced that St. Vincent’s Private Hospital in Dublin, Ireland, has chosen to implement ...

Time May 16, 2024
arrow
News | Artificial Intelligence

May 16, 2024 — deepc, the globally recognized digital medicine pioneer and market leader behind the leading AI operating ...

Time May 16, 2024
arrow
News | Enterprise Imaging

May 15, 2024 — etherFAX announced the expansion of its partnership with Hyland, a leading global provider of intelligent ...

Time May 15, 2024
arrow
News | Cybersecurity

May 13, 2024 — In the wake of the cybersecurity breach targeting the prominent healthcare system Ascension, a new study ...

Time May 13, 2024
arrow
News | Radiology Imaging

May 13, 2024 — National Basketball Association (NBA), the National Basketball Players Association (NBPA), and the Next ...

Time May 13, 2024
arrow
News | Breast Imaging

May 10, 2024 — According to the Summa Cum Laude Award-Winning Online Poster presented during the 124th ARRS Annual ...

Time May 10, 2024
arrow
News | Radiation Oncology

May 10, 2024 — Mariana Oncology, a fully integrated biotechnology company pioneering a new era of radiopharmaceutical ...

Time May 10, 2024
arrow
News | ARRS

May 8, 2024 — Compared to males, women in radiology are at a consistently higher risk of not matching into diagnostic ...

Time May 08, 2024
arrow
News | Contrast Media

May 8, 2024 — Swedish biotech company Ascelia Pharma AB has announced that its liver imaging drug candidate, Orviglance ...

Time May 08, 2024
arrow
Subscribe Now